Wr. Waters et al., Antigen-specific proliferation of porcine CD8 alpha alpha cells to an extracellular bacterial pathogen, IMMUNOLOGY, 101(3), 2000, pp. 333-341
A vaccine inducing protective immunity to a spirochaete-induced colitis of
pigs predominantly stimulates expansion of CD8(+) cells in vivo and in anti
gen-stimulated lymphocyte cultures. CD8(+) cells, however, are rarely consi
dered necessary for protection against extracellular bacterial pathogens. I
n the present study, pigs recovering from colitis resulting from experiment
al infection with Brachyspira (Serpulina) hyodysenteriae had increased perc
entages of peripheral blood CD4(-) CD8(+) (alpha alpha -expressing) cells c
ompared with non-infected pigs. CD8 alpha alpha (+) cells proliferated in a
ntigen-stimulated cultures of peripheral blood mononuclear cells from B. hy
odysenteriae-vaccinated pigs. Proliferating CD8 alpha alpha (+) cells consi
sted of CD4(-), CD4(+) and gamma delta T-cell receptor-positive cells. CD4(
-) CD8 alpha beta (+) cells from vaccinated or infected pigs did not prolif
erate upon in vitro antigen stimulation. Of the CD8 alpha alpha cells that
had proliferated, flow cytometric analysis indicated that the majority of t
he CD4(+) CD8(+) cells were large (i.e. lymphoblasts) whereas the CD4(-) CD
8(+) cells were predominantly small. Addition of monoclonal antibodies (mAb
) specific for either porcine major histocompatibility complex (MHC) class
I or class II antigens diminished B. hyodysenteriae-specific proliferative
responses whereas addition of mAb to porcine MHC II, but not porcine MHC I,
reduced the CD8 alpha alpha response. In vitro depletion of CD4(+) cells b
y flow cytometric cell sorting diminished, but did not completely abrogate,
the proliferative response of cells from vaccinated pigs to B. hyodysenter
iae antigen stimulation. These results suggest that CD8 alpha alpha cells a
re involved in recovery and possibly protection from a spirochaete-induced
colitis of pigs; yet, this response appears to be partially dependent upon
CD4(+) cells.